Noted in 10Q verbage "The change in circulating t
Post# of 145465
![Avatar](/images/ProfileImages/no_avatar_available.jpg)
tumor cells ("CTCs"
![](/images/icons/icon_wink.gif)
will be used as an initial prognostic marker for efficacy. Up to 48 patients are
expected to be enrolled in this study."
This is for the TNBC trial, so it seems we should not expect CTC updates for at least 21 days per patient at best.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)